Search Results - Alexander Fossa

Refine Results
  1. 1

    Late-effect awareness and follow-up of cancer in general practice by Siri A. Eikeland, Knut B. Smeland, Mette Brekke, Cecilie E. Kiserud, Alexander Fosså

    Get full text
    Article


  2. 2

    Controversies in the Treatment of Classical Hodgkin Lymphoma by Dennis A. Eichenauer, Marc André, Peter Johnson, Alexander Fossa, Olivier Casasnovas, Andreas Engert

    Published in HemaSphere (2018-10-01)
    Get full text
    Article


  3. 3

    Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen by Arne Kolstad, Harald Holte, Alexander Fosså, Grete Fossum Lauritzsen, Peter Gaustad, Dag Torfoss

    Published in Haematologica (2007-01-01)
    Get full text
    Article


  4. 4

    Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years. by Dlawer Abdulla Barzenje, Milada Cvancarova Småstuen, Knut Liestøl, Alexander Fosså, Jan Delabie, Arne Kolstad, Harald Holte

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  5. 5

    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered by Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, Boris Böll, Markus Dietlein, Carsten Kobe, Helen Goergen, Andreas Engert

    Published in HemaSphere (2018-06-01)
    Get full text
    Article


  6. 6

    Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma by Alv A. Dahl, Knut B. Smeland, Siri Eikeland, Unn-Merete Fagerli, Hanne S. Bersvendsen, Alexander Fosså, Cecilie E. Kiserud

    Published in Acta Oncologica (2024-08-01)
    Get full text
    Article


  7. 7

    Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. by Alexander Fosså, Knut Halvor Smeland, Øystein Fluge, Karl Johan Tronstad, Jon Håvard Loge, Øivind Midttun, Per Magne Ueland, Cecilie Essholt Kiserud

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  8. 8

    Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study by Kjersti Lia, Rasmus R.K. Jørgensen, Bente L.Wold, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Alexander Fosså

    Published in Haematologica (2023-10-01)
    Get full text
    Article


  9. 9

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. by Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Karl J Tronstad, Olav Mella, Øystein Fluge

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  10. 10

    Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result... by Elisa J. Pulczynski, Outi Kuittinen, Martin Erlanson, Hans Hagberg, Alexander Fosså, Mikael Eriksson, Marie Nordstrøm, Bjørn Østenstad, Øystein Fluge, Sirpa Leppä, Bente Fiirgaard, Hanne Bersvendsen, Unn-Merete Fagerli

    Published in Haematologica (2015-04-01)
    Get full text
    Article


  11. 11

    Response to Comment on: A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma by Kjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, Bente L. Wold, Ninja Övergaard, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Daniel Molin, Alexander Fosså

    Published in Haematologica (2025-06-01)
    Get full text
    Article


  12. 12

    A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma by Kjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, Bente L. Wold, Ninja Övergaard, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Daniel Molin, Alexander Fosså

    Published in Haematologica (2025-04-01)
    Get full text
    Article


  13. 13

    T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients by Ninja Övergaard, Kjersti Lia, Peter Asdahl, Per Wikman, Ingrid Glimelius, Ingemar Lagerlöf., Ann-Sofie Johansson, Lotta Hansson, Gunilla Enblad, Johan Linderoth, Christina Goldkuhl, Alexander Fosså, Peter Kamper, Daniel Molin

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  14. 14

    Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway by Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Arne Kolstad, Jon H. Loge, Martin Maisenhölder, Stein Kvaløy, Harald Holte

    Published in Haematologica (2015-06-01)
    Get full text
    Article


  15. 15

    Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the pros... by Alexander Fosså, Daniel Molin, Paul J. Bröckelmann, Gundolf Schneider, Ulf Schnetzke, Johan Linderoth, Peter M. H. Kamper, Sirpa M. Leppä, Julia Meissner, Valdete Schaub, Kjersti Lia, Michael Fuchs, Peter Borchmann, Boris Böll

    Published in HemaSphere (2025-03-01)
    Get full text
    Article


  16. 16

    T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway by Joshua P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. øvlisen, Daniel Molin, Ingrid Glimelius, Anna Marklund, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer El-Galaly, Sandra Eloranta

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  17. 17

    P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) by Muhit Ozcan, Yuqin Song, Seung Tae Lee, Felix Mensah, Dipenkumar Modi, Alexander Fossa, Won Seog Kim, Ewa Paszkiewicz-Kozik, Yazeed Sawalha, Omur Gokmen Sevindik, Lalita Norasetthada, Armando Santoro, Kumudu Pathiraja, Samhita Chakraborty, Patricia Marinello, David Lavie

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  18. 18

    Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease. by Christopher S Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R Ruth, Mitsuhiro Kawano, Yasuharu Sato, Katie Stone, Signe Spetalen, Federico Valdivieso, Michael D Feldman, Amy Chadburn, Alexander Fosså, Frits van Rhee, W Ian Lipkin, David C Fajgenbaum

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  19. 19

    Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up by Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson, Øystein Fluge, Sirpa Leppä, Bjørn Østenstad, Alexander Fosså, Mikael Eriksson, Tarec El-Galaly, Hanne Kuitunen, Karin Papworth, Maria Ljungqvist, Martin B. Pedersen, Marjukka Pollari

    Published in Haematologica (2024-03-01)
    Get full text
    Article


  20. 20

    Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients by Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob H. Christensen, Ulf Schnetzke, Michael Fuchs, Janina Jablonski, Dennis A. Eichenauer, Bastian von Tresckow, Wolfram Klapper, Carsten Kobe, Peter Borchmann, Alexander Fosså

    Published in HemaSphere (2025-08-01)
    Get full text
    Article


Search Tools: